Stanford University
Showing 13,461-13,480 of 36,326 Results
-
Michelle Huffaker, MD
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioDr. Michelle Huffaker is a board-certified, fellowship-trained allergist and immunologist with Stanford Health Care. She is a clinical assistant professor in the Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine at Stanford University School of Medicine.
Dr. Huffaker specializes in diagnosing and treating allergies and health conditions that affect the immune system. She is particularly interested in asthma, food allergies, and allergic rhinitis.
Dr. Huffaker’s research is focused on treatments that achieve long-lasting remission for allergic and immunologic diseases, such as food allergies and allergic rhinitis. Dr. Huffaker is the director of clinical and translational medicine for the allergy portfolio of the Immune Tolerance Network (ITN), a clinical research consortium funded by the National Institute of Allergy and Infectious Diseases (NIAID). The ITN focuses on achieving immune tolerance in conditions where the body attacks healthy cells (immune-mediated diseases). Dr. Huffaker leads the development, conduct, and analysis of ITN clinical trials.
Dr. Huffaker has published her research in peer-reviewed journals, such as Allergy, The Journal of Allergy and Clinical Immunology, and World Allergy Organization Journal. She has presented to her peers at international, national, and regional meetings, including those of the European Academy of Allergy and Clinical Immunology (EAACI), the American Academy of Allergy, Asthma, and Immunology (AAAAI), and the American College of Allergy, Asthma, and Immunology (ACAAI).
Dr. Huffaker is a fellow of AAAAI and a member of AAAAI, EAACI, and the Western Society of Allergy, Asthma, and Immunology. -
Lynne C. Huffman
Professor (Teaching) of Pediatrics (Developmental-Behavioral Pediatrics), Emerita
Current Research and Scholarly InterestsResearch interests and activities include (1) shared decision-making in clinical care; (2) medical education research; (3) the early identification and treatment of behavioral problems, particularly in children with special health care needs; and (4) community-based mental health/educational program evaluation and outcomes measurement.
-
Adrian Hugenmatter
Director of Protein Engineering
BioDr. Adrian Hugenmatter joined ChEM-H as Director of Protein Engineering in 2021. In his role, Dr. Hugenmatter heads the Protein Engineering Laboratory at the Nucleus and is responsible for the development of therapeutic proteins at the Innovative Medicines Accelerator (IMA). Dr. Hugenmatter obtained his PhD in the laboratory of Prof. Donald Hilvert at the Swiss Federal Institute of Technology in Zurich (ETH Zurich, Switzerland), where he gained initial experience in the fields of enzymology, antibody engineering and directed evolution. Fascinated by protein engineering, he moved to the laboratory of Prof. Dan Tawfik at the Weizmann Institute of Science (Israel), where he studied molecular evolution and its application in protein design. Dr. Hugenmatter then worked for more than a decade as a researcher and team leader at Roche. During this time, he was involved in the development and optimization of several antibody lead candidates for therapeutic applications in neuroscience and oncology.
-
Robert Huggins
Professor of Materials Science and Engineering, Emeritus
BioProfessor Huggins joined Stanford as Assistant Professor in 1954, was promoted to Associate Professor in 1958, and to Professor in 1962.
His research activities have included studies of imperfections in crystals, solid-state reaction kinetics, ferromagnetism, mechanical behavior of solids, crystal growth, and a wide variety of topics in physical metallurgy, ceramics, solid state chemistry and electrochemistry. Primary attention has recently been focused on the development of understanding of solid state ionic phenomena involving solid electrolytes and mixed ionic-electronic conducting materials containing atomic or ionic species such as lithium, sodium or oxygen with unusually high mobility, as well as their use in novel battery and fuel cell systems, electrochromic optical devices, sensors, and in enhanced heterogeneous catalysis. He was also involved in the development of the understanding of the key role played by the phase composition and oxygen stoichiometry in determining the properties of high temperature oxide superconductors.
Topics of particular recent interest have been related to energy conversion and storage, including hydrogen transport and hydride formation in metals, alloys and intermetallic compounds, and various aspects of materials and phenomena related to advanced lithium batteries.
He has over 400 professional publications, including three books; "Advanced Batteries", published by Springer in 2009, "Energy Storage", published by Springer in 2010, and Energy Storage, Second Edition in 2016. -
Albert Hughes
Product Owner, H&S Dean's Office
Current Role at StanfordI am a member of the H&S IT Web Services team, which advises, builds and supports the web presence of H&S units.
As Product Owner, I support all 100+ units on the H&S Drupal content management platform. My responsibilities include managing ongoing software development efforts, as well as overseeing the longer-term roadmap of the platform.
